Queue Raises $12.6 Million to Expand Autonomous Pharmacy Kiosks

PALO ALTO, Calif. - Queue has raised $12.6 million in an oversubscribed seed round to launch and expand its autonomous robotic pharmacy system, aiming to modernize a critical piece of healthcare infrastructure that has remained largely stagnant for decades. The financing was led by AlleyCorp and comes on the heels of a $6 million pre-seed round previously led by Riot Ventures. Other participants in the funding include House Fund, Ubiquity Ventures, Grep VC, and Banter Capital. This capital infusion arrives at a time when the retail pharmacy sector is facing acute pressure from labor shortages and administrative overhead, forcing many traditional operators to consolidate or shutter locations entirely.

The Palo Alto company is building compact pharmacy locations that automate medication storage, verification, and dispensing, fundamentally reimagining the physical requirements of a prescription counter. By utilizing advanced robotics, Queue’s systems are designed to handle the high volume of routine fulfillment that typically consumes the majority of a technician's workday. These units act as self-contained micro-pharmacies, capable of maintaining inventory integrity while freeing up the essential human elements of the pharmacy workflow for higher-value clinical tasks.

Central to the Queue model is the integration of remote professional oversight. Patients can collect prescriptions from a kiosk, while pharmacists provide remote oversight and clinical support via digital interfaces. This hybrid approach ensures that while the physical act of retrieval is automated, the legal and safety requirements for pharmacist consultation remain intact. By decoupling the pharmacist's physical presence from the pill-counting mechanism, Queue enables a single clinician to potentially oversee multiple points of distribution, an efficiency gain that could be vital for maintaining service levels in underserved regions.

Queue says the model can extend operating hours and place pharmacy access in communities where a full store is difficult to staff. Traditional pharmacy operations are often limited by the availability of licensed staff willing to work overnight or in rural locations, leading to 'pharmacy deserts' where patients must travel significant distances for basic medications. A robotic system, by contrast, can remain active 24 hours a day without the incremental overhead of staffing a full retail footprint, providing a bridge for patients who require flexibility outside of standard business hours.

Pharmacy closures and workforce constraints have made access uneven, particularly outside dense urban centers. Over the past two years, several major national chains have announced the closure of hundreds of stores, citing labor costs and shifting consumer habits. When a community loses its only pharmacy, the ripple effects on public health are documented, often leading to lower medication adherence rates and increased emergency room visits. Queue’s entry into this market aligns with a broader industry shift toward decentralized healthcare delivery models that emphasize local convenience and technological efficiency.

Automation may reduce the physical footprint required for a location and let a pharmacist supervise routine fulfillment while focusing on counseling and complex cases. In a standard pharmacy environment, pharmacists spend an estimated majority of their time on mechanical tasks like counting pills, labeling bottles, and managing inventory. By delegating these repetitive actions to a robotic system, the profession may pivot toward its clinical potential, allowing pharmacists to spend more time on drug-interaction screenings and patient education, which are increasingly important as the population ages.

The system still depends on accurate prescriptions, secure inventory, and a reliable escalation path. While the hardware handles the physical movement of goods, the underlying software must integrate seamlessly with existing electronic health records and provider networks. Any friction in the data transfer between the prescribing physician and the dispensing robot could lead to delays, necessitating a robust technical architecture that maintains the same level of reliability as a legacy pharmacy counter.

Medication dispensing is a safety-critical and heavily regulated activity that leaves little room for error. Queue must meet state pharmacy requirements, protect patient information, and prevent diversion. Because pharmaceutical inventory involves high-value and controlled substances, the physical security of these kiosks is a primary concern. The company’s engineering must account for both digital cybersecurity threats and physical tampering, ensuring that the automated environment is at least as secure as a locked back-room pharmacy at a big-box retailer.

A robotic workflow also needs clear procedures for insurance problems, unavailable drugs, and patients who need immediate human attention. The complexities of the American payer system often lead to rejected claims at the point of sale, which traditionally require a technician to resolve manually. Queue will need to demonstrate that its interface can handle these nuances or provide a seamless handoff to a remote specialist to prevent patient frustration and ensure that life-saving medications are not withheld due to administrative errors.

Deployment will require trust from regulators, clinicians, and local communities. State boards of pharmacy are historically conservative regarding the introduction of new dispensing technologies, prioritizing patient safety over technical novelty. Queue will have to navigate a patchwork of state-level regulations that govern how and where remote dispensing can occur. Building a track record of error-free operation will be essential to convincing skeptical regulators that a robot can safely replace a physical pharmacy counter without compromising the public interest.

The financing will support manufacturing, software, and the launch of additional sites as the company moves out of stealth and into active operations. Scaling a hardware-heavy business in the healthcare space requires significant capital for inventory and deployment, but the oversubscribed nature of the round suggests strong investor confidence in the scalability of the autonomous kiosk model. These funds will likely be used to refine the robotic picking mechanisms and enhance the user interface to ensure the kiosks are accessible to patients of all ages and technological fluencies.

Queue's opportunity is not simply a faster vending machine; it is a new operating model for pharmacy care. As the retail landscape continues to shift toward e-commerce and automated services, the pharmacy is one of the last remaining retail categories to undergo a complete technological reimagining. The company is positioning itself at the intersection of retail tech and health tech, betting that the future of the industry lies in a leaner, more agile physical presence supported by a robust digital backend.

The company will need to show that automated locations improve access while maintaining the accuracy, counseling, and accountability patients expect from a licensed pharmacy. Success will be measured not just by the number of kiosks deployed, but by the clinical outcomes of the patients using them. If Queue can prove that its system reduces errors and increases adherence by making medications more accessible, it could become a standard component of the modern healthcare ecosystem.

Looking ahead, the industry will be watching how Queue manages the integration of its units into existing community infrastructures. Whether these kiosks appear in supermarkets, transit hubs, or as standalone micro-clinics, their success will depend on their ability to blend into the patient's daily life. The challenge for Queue will be maintaining the 'human touch' of healthcare in an increasingly automated world, ensuring that the machine is a tool for better care rather than a barrier between the patient and their pharmacist.

As the $12.6 million seed round fuels the next phase of growth, the broader healthcare market is looking for solutions to the rising costs of traditional brick-and-mortar operations. Queue’s approach offers a potential template for how other highly regulated, labor-intensive sectors might adapt to a changing workforce. If the Palo Alto startup can execute on its vision, the traditional pharmacy counter may soon be joined, or in some cases replaced, by the precision of robotic fulfillment.